Welcome to Sysmex Inostics
Empowering discoveries in oncology
We provide ultra-sensitive liquid biopsy solutions for exceptional ctDNA detection. We partner with BioPharma companies to aid cancer drug and diagnostic development to monitor therapy response, identify targetable resistance, and detect minimal residual disease (MRD).
Approach
Our Products & Solutions
Sensitive and specific liquid biopsy
News & Events
The latest
Role of PD-1/PD-L1 pathway in the development of Head and neck squamous cell carcinoma (HNSCC)
The human immune system has the innate capability to recognize and eliminate cancer cells. However,…
Key differences between HPV-positive and HPV-negative head and neck squamous cell carcinomas (HNSCC)
Head and neck squamous cell carcinomas (HNSCC) develop from the mucosal epithelium in the oral…
Sysmex Inostics & QIAGEN Highlight Cancer Companion Diagnostics Alliance at ASCO 2022
Two poster presentations utilizing Sysmex Inostics technology to be featured Baltimore, MD, June 2, 2022…